WebAug 28, 2024 · Investors in small-cap biotech stocks know risks are high, as prices regularly swing wildly in either direction based on catalysts. Gritstone currently has over $90 million of cash on hand... WebOct 8, 2024 · Gritstone seems correctly valued at 2x-3x its book value per share. It is quite beneficial that the company was able to seduce a long list of institutional investors. It tells a lot about the company.
Gritstone Oncology Inc Stock News (GRTS) - Page 4 - Public.com
WebFeb 1, 2024 · Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. ... Jacquie Ross, Investors (650) 425-8408 Mark Snyder, Media (650) 446-6957 Gritstone Contacts: Alexandra Santos, Investors (510) 871-6161 … WebGritstone Oncology Inc (NASDAQ:GRTS) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual … ifb laundry trolley near me
Gritstone bio LinkedIn
WebJul 22, 2024 · Gritstone Oncology is not a large company by global standards. It has a market capitalization of US$138m, which means it wouldn't have the attention of many institutional investors. WebApr 14, 2024 · 48.1% of Gritstone bio shares are held by institutional investors. 4.5% of Gritstone bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. ... immuno-oncology, oncology, and respiratory … WebMar 3, 2024 · For the last reported quarter, it was expected that Gritstone Oncology, Inc. Would post a loss of $0.68 per share when it actually produced a loss of $0.69, delivering a surprise of -1.47%.... ifb lite